Life Vital ReviewEvidence notes on men's health

Blood Flow And Size: What Actually Changes In Men After 40

Most of what men read on this subject treats size as a matter of tissue. The measurement literature points somewhere else entirely: at how completely the tissue fills.

By R. Whitfield · Updated 4 September 2026 · 9 min read

The short version. Erect length is governed by how much blood the two dorsal chambers hold at full pressure. Nothing about that is fixed tissue. When filling drops, measured size drops with it, and the man reasonably concludes he has lost something structural. The measurement literature does not support that conclusion.

What the measurements say

The largest pooled analysis of the subject, covering more than fifteen thousand men, put average erect length at 5.16 inches and average erect circumference at 4.6 inches. Flaccid length averaged 3.6 inches. The distribution is narrower than almost every man assumes, and the gap between what men estimate as average and what the tape actually reports is one of the more consistent findings in the field.

That gap matters here for a practical reason. A man who believes average is well above what it is will read a normal measurement as a deficit, and will go looking for a fix to a problem the data does not show he has.

Where size actually goes

Filling, not fibre

An erection is hydraulic. Arterial inflow raises pressure inside the corpora cavernosa while venous outflow is restricted. Full length and full girth are reached only at full pressure. When arterial inflow drops even modestly, the chambers reach a lower ceiling, and the result is shorter and narrower than the same man measured a decade earlier. The tissue did not shrink. It stopped being filled.

The pad above it

The suprapubic fat pad sits over the pubic bone and physically conceals part of the shaft. Weight gained there does not shorten anything, it hides it. This is the one variable in the entire subject that reliably moves in both directions, and it moves without any product at all.

Elastic properties

The tunica albuginea, the sheath around the chambers, changes with age. Reduced compliance means the sheath resists expansion, and the ceiling comes down again slightly. This one is real, and no supplement addresses it.

What the evidence supports

Supported

Losing weight above the pubic bone

The most reliable change available, the least discussed, and the only one where the man does the work rather than buying something. As the pad reduces, buried shaft becomes visible. Nothing grew. Something stopped being hidden.

Supported

Anything that genuinely improves endothelial function

Blood flow is the lever the whole subject turns on. Aerobic conditioning, blood pressure control, glycaemic control and sleep all measurably affect nitric oxide availability, and nitric oxide availability determines how completely the chambers fill. This is unglamorous, slow and better documented than anything else on the page.

Limited evidence

Mechanical traction over long periods

Traction protocols have produced modest length gains in small controlled series, on the order of a fraction of an inch, at the cost of several hours daily for months. The effect appears real and the compliance burden is why almost nobody sustains it.

Depends on the claim

Oral formulations, and what they are actually claiming

This category gets judged as one thing when it is two. A formulation aimed at blood flow, nitric oxide signalling and firmness is working on a pathway the literature recognises, and that is where icariin sits. A formulation promising to permanently alter anatomy is making a structural claim, and structural claims have no published support behind them.

So the useful question is not whether these work. It is which of the two things the label in front of you is claiming.

What does not hold up

Risk of injury

Manual stretching routines

Widely promoted in forums, unsupported by controlled data, and associated with case reports of bruising, fibrosis and worsened function. The mechanism people imagine, micro-tearing tissue into permanent growth, is not how this tissue behaves.

FDA warnings

Honey sachets sold as enhancers

Products of this kind sold at convenience stores and on social platforms have repeatedly been found by the FDA to contain undeclared prescription compounds in unmeasured amounts. A man who believes he is taking something natural is taking an unmeasured dose of a vasodilator. Combined with nitrates or blood pressure medication, that can drop pressure severely.

Where the honey claim comes from

Three separate things travel under the same name, and conflating them is why the subject is such a mess.

The first is Apis laboriosa honey from the Himalayan cliffs, a real product with a long documented history. The second is grayanotoxin, the compound in that honey responsible for its effects, which is genuinely toxic in quantity and causes bradycardia and hypotension. The third is icariin, an entirely different compound from a different plant, which has a weak but measurable action on the same enzyme pathway that prescription oral therapies target.

Only the third has a coherent mechanism for blood flow. It is also the only one of the three that is not the honey.

What this costs, compared

RouteAnnual costEvidence
Weight loss above the pubic bone$0Consistent
Conditioning and pressure control$0 to $600Consistent
Traction device, used as directed$130 to $400Small effect, high burden
Generic prescription tablets$82 to $324Strong, for function not size
Surgical augmentation$8,000 to $22,000High complication rate

Frequently asked questions

Can anything actually add length?

Two things move the measurement. Reducing fat above the pubic bone uncovers buried shaft, and improved arterial filling restores the ceiling a man previously reached. Neither adds tissue. Traction protocols have shown small gains in controlled series at a very high compliance cost.

Why does it look smaller than it did at 30?

Usually two changes at once. The suprapubic pad conceals part of the shaft, and reduced arterial inflow means the chambers reach a lower pressure ceiling. Both are common after 40 and both are partly reversible.

Is the honey sold as a male enhancer safe?

Not automatically. The FDA has repeatedly found sachets of this kind containing undeclared prescription compounds in unmeasured doses. Men take them believing they are natural, and combined with nitrates or blood pressure medication an unmeasured vasodilator can cause a severe drop in pressure.

What is icariin?

A compound from Epimedium with weak measurable activity on the same enzyme pathway prescription oral therapies act on. Human evidence is limited and the effect is far smaller. It is the only part of the honey story with a coherent mechanism, and it does not come from honey.

When should a man see a doctor about this?

Earlier than most do. A decline in fullness is frequently the first visible sign of cardiovascular disease or undiagnosed diabetes. Treating it as a cosmetic concern delays a conversation that may actually be about the heart.

Where readers keep asking to look

Since this piece was published, the question in the inbox has not been about mechanism. It has been about sourcing: if icariin is the compound with the plausible pathway, what a standardised version looks like on a label. We do not sell anything and we take no position on any brand. The formulation most often named in correspondence is linked below so you can read the panel yourself. Check the standardisation, check what else is in it, and speak with your physician first, particularly if you take nitrates or blood pressure medication.

Read the ingredient panel readers keep asking about

References

  1. Am I normal? A systematic review and construction of nomograms for flaccid and erect penis length and circumference in up to 15,521 men. BJU International. PMID 25487360.
  2. Penile enlargement: from medication to surgery. A systematic review of interventions. PMID 30740085.
  3. Penile traction therapy and Peyronie's disease: a state of the art review. PMID 30828111.
  4. Erectile dysfunction as a predictor of cardiovascular events. PMID 21414553.
  5. Icariin and its derivatives: a review of pharmacological activity. PMID 27472837.
  6. Mad honey poisoning: a review of the literature. PMID 22314225.
  7. Tainted sexual enhancement products: FDA health fraud advisories.
  8. Obesity and male sexual function: a review of the mechanisms. PMID 26005996.
  9. Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease? PMID 10022771.
  10. Aerobic exercise training and erectile function: a meta-analysis. PMID 29661646.